Precision BioSearch is delighted to be sponsoring the OBN Awards 2022
Precision BioSearch is delighted to congratulate Tom Coulter on his appointment as Head, Drug Discovery Programs and Partnerships with Dalriada Drug Discovery.
Precision BioSearch secures CSO for leading cell and gene therapy company, Ixaka
Precision BioSearch is delighted to congratulate Tom Coulter on his appointment as Head, Drug Discovery Programs and Partnerships with Dalriada Drug Discovery.
Tom Coulter joins Dalriada as Head, Drug Discovery Programs and Partnerships
Precision BioSearch is delighted to congratulate Tom Coulter on his appointment as Head, Drug Discovery Programs and Partnerships with Dalriada Drug Discovery.
New Oxford spin-out, Alethiomics, appoints Dr Edward Ainscow as CSO
Precision BioSearch is pleased to have partnered with Oxford Science Enterprises during the launch phase of Alethiomics to secure Dr Edward Ainscow as CSO
‘What Makes a Biotech Executive Stand Out?’ Our Co-founders speak with Labiotech
Precision BioSearch is pleased to have partnered with Oxford Science Enterprises during the launch phase of Alethiomics to secure Dr Edward Ainscow as CSO
Our Co-founder, Malcolm Silander, presents at the OBN Awards 2021
Precision BioSearch is delighted to congratulate Tom Coulter on his appointment as Head, Drug Discovery Programs and Partnerships with Dalriada Drug Discovery.
Our Co-founder chairs a panel with LSX on ‘Building a diverse leadership team and board’
Precision BioSearch Co-founder, Malcolm Silander, was pleased to chair a panel webinar addressing the continuing issue of diversity within venture backed biotech.